
    
      HCC Patients classified as BCLC stage C present with PVTT, and the recommended first-line
      treatment is systemic therapy with sorafenib according to updated Barcelona Clinical Liver
      cancer (BCLC) treatment algorithms.However, recent data from observational studies suggest
      that the combination of TACE and SBRT would be as effective as sorafenib.
    
  